| Barriers to COVID-19 health products in low-and middle-income countries during the COVID-19 pandemic: A rapid systematic review and evidence synthesis E Boro, B Stoll Frontiers in public health 10, 928065, 2022 | 36 | 2022 |
| The role and impact of faith-based organisations in the management of and response to COVID-19 in low-resource settings: Policy & practice note E Boro, T Sapra, JF de Lavison, C Dalabona, V Ariyaratne, A Samsudin Religion and Development 1 (1), 132-145, 2022 | 21 | 2022 |
| Antiracism in leading public health universities, journals and funders: commitments, accountability and the decision-makers A Rahman-Shepherd, NA Erondu, B Anwar, E Boro, TD Chau, RR Guinto, ... BMJ global health 8 (3), e010376, 2023 | 7 | 2023 |
| The need for metrics to measure progress on racial equity in global public health and medicine MS Khan, RR Guinto, E Boro, A Rahman-Shepherd, NA Erondu The Lancet 400 (10368), 2019-2021, 2022 | 3 | 2022 |
| Resisting unchecked pragmatism in global health J Smith, E Boro, EJL Kwong, M Schmidt-Sane The Lancet Global Health 11 (8), e1176-e1177, 2023 | 2 | 2023 |
| How to make AMR diagnostics globally applicable in low-and-middle-income country (LMIC) settings MA Africa https://longitudeprize.org/resources/resources-how-to-make-amr-diagnostics …, 2022 | | 2022 |
| Unjust and Unsustainable Choices for Physicians in Nigeria E Boro https://www.healthlawinst.org/post/unjust-and-unsustainable-choices-for …, 2019 | | 2019 |
Ngozi EronduGlobal Health Programme, Chatham House在 lshtm.ac.uk 的电子邮件经过验证
